Insider Activity of Chang David D
According to the SEC Form 4 filings, Chang David D, being in a position of
- President and CEO at Allogene Therapeutics, Inc.,оver the last 12 months, has bought 0 shares, and sold 92671 share for $168,754,over all time since 2018-10-15, has bought 80000 shares for $1.44M, and sold 177502 shares for $1.93M.
Biography of Chang David D
No biography is available at this moment.